CA3137417C - Dissolvable polymeric eye inserts and method of using same - Google Patents

Dissolvable polymeric eye inserts and method of using same Download PDF

Info

Publication number
CA3137417C
CA3137417C CA3137417A CA3137417A CA3137417C CA 3137417 C CA3137417 C CA 3137417C CA 3137417 A CA3137417 A CA 3137417A CA 3137417 A CA3137417 A CA 3137417A CA 3137417 C CA3137417 C CA 3137417C
Authority
CA
Canada
Prior art keywords
insert
eye
polymeric
polymeric eye
inserts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3137417A
Other languages
English (en)
French (fr)
Other versions
CA3137417A1 (en
Inventor
Howard Allen Ketelson
Rekha Rangarajan
Walter R. Laredo
Stephen John Collins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of CA3137417A1 publication Critical patent/CA3137417A1/en
Application granted granted Critical
Publication of CA3137417C publication Critical patent/CA3137417C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3137417A 2019-05-02 2020-05-01 Dissolvable polymeric eye inserts and method of using same Active CA3137417C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962841901P 2019-05-02 2019-05-02
US62/841,901 2019-05-02
US201962927885P 2019-10-30 2019-10-30
US62/927,885 2019-10-30
PCT/IB2020/054148 WO2020222195A1 (en) 2019-05-02 2020-05-01 Dissolvable polymeric eye inserts and method of using same

Publications (2)

Publication Number Publication Date
CA3137417A1 CA3137417A1 (en) 2020-11-05
CA3137417C true CA3137417C (en) 2024-01-09

Family

ID=70554143

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3137417A Active CA3137417C (en) 2019-05-02 2020-05-01 Dissolvable polymeric eye inserts and method of using same

Country Status (12)

Country Link
US (1) US12102559B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962450A1 (cg-RX-API-DMAC7.html)
JP (1) JP7350885B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004969A (cg-RX-API-DMAC7.html)
CN (1) CN113795242B (cg-RX-API-DMAC7.html)
AU (1) AU2020266339B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021019774A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137417C (cg-RX-API-DMAC7.html)
MX (1) MX2021013428A (cg-RX-API-DMAC7.html)
SG (1) SG11202110514RA (cg-RX-API-DMAC7.html)
TW (1) TWI826685B (cg-RX-API-DMAC7.html)
WO (1) WO2020222195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US12491263B2 (en) 2019-05-13 2025-12-09 University of Pittsburgh—of the Commonwealth System of Higher Education Polymer-based implant for retinal therapy and methods of making and using the same
CN115066232B (zh) 2020-02-06 2024-12-10 视尔普斯眼科公司 用于治疗眼病的组合物和方法
EP4142664A4 (en) 2020-04-27 2024-05-29 Ocular Therapeutix, Inc. METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
EP4432990A4 (en) * 2021-11-16 2025-07-30 Univ Pittsburgh Commonwealth Sys Higher Education POLYMER-BASED GEL IMPLANT FOR RETINAL THERAPY AND METHODS OF MAKING AND USING THE SAME
WO2023119231A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device and kit for corneal surface protection
WO2023119235A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device for promoting healing of wounds
TW202339703A (zh) * 2021-12-23 2023-10-16 瑞士商愛爾康公司 用於藥物遞送的可溶解醫療裝置
WO2023214027A1 (en) * 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
US20240207174A1 (en) * 2022-12-23 2024-06-27 Alcon Inc. Dissolvable polymeric eye inserts
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
ATE240698T1 (de) 1995-06-07 2003-06-15 Keravision Inc Radiales intrastromales hornhautimplantat
CA2602525A1 (en) 2005-03-21 2006-09-28 Macusight, Inc. Drug delivery systems for treatment of diseases or conditions
EP1973421A2 (en) * 2005-12-23 2008-10-01 Cadbury Adams USA LLC Compositions providing a sensation substantially similar to that provided by menthol
KR101555291B1 (ko) 2007-02-09 2015-09-30 알콘, 인코퍼레이티드 세가지 폴리머의 상승성 배합물을 함유하는 안과 조성물
US20130244978A1 (en) * 2007-09-14 2013-09-19 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
US20130172357A1 (en) * 2011-02-03 2013-07-04 Eye Therapies Llc Compositions and Methods for Treatment of Glaucoma
US20120215184A1 (en) 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US20140107025A1 (en) 2012-04-16 2014-04-17 Jade Therapeutics, Llc Ocular drug delivery system
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
RU2683651C2 (ru) 2013-06-18 2019-04-01 Иван Дмитриевич Захаров Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
JP6200108B2 (ja) 2014-06-20 2017-09-20 クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ 眼感染症の治療のための眼科用組成物
US9931306B2 (en) 2014-09-06 2018-04-03 Integral Biosystems Llc Methods and biocompatible compositions to achieve sustained drug release in the eye

Also Published As

Publication number Publication date
CA3137417A1 (en) 2020-11-05
WO2020222195A1 (en) 2020-11-05
TW202106286A (zh) 2021-02-16
US20200345544A1 (en) 2020-11-05
JP7350885B2 (ja) 2023-09-26
AU2020266339B2 (en) 2023-12-07
JP2022530758A (ja) 2022-07-01
AU2020266339A1 (en) 2021-12-23
CN113795242B (zh) 2026-06-16
KR20220004969A (ko) 2022-01-12
TWI826685B (zh) 2023-12-21
US12102559B2 (en) 2024-10-01
EP3962450A1 (en) 2022-03-09
CN113795242A (zh) 2021-12-14
BR112021019774A2 (pt) 2021-12-07
MX2021013428A (es) 2021-12-10
SG11202110514RA (en) 2021-11-29

Similar Documents

Publication Publication Date Title
US12102559B2 (en) Dissolvable polymeric eye inserts and method of using same
US11779537B2 (en) Dissolvable polymeric eye inserts with a biodegradable polymer and method of using the same
CN107847604A (zh) 眼用原位凝胶处方
SA521430043B1 (ar) صياغات من المركب 4-(7- هيدروكسي-2- أيزوبروبيل-4- أوكسو-4h- كوينازولين-3- يل) - بنزونيتريل
US20230372236A1 (en) Drug containing dissolvable ocular inserts and method of using same
Jothi et al. In-situ ophthalmic gels for the treatment of eye diseases
RU2791026C1 (ru) Растворимые полимерные глазные вставки и способ их применения
JP7358526B2 (ja) 向上した眼の快適性を提供する組成物
CN102727874B (zh) 重组水蛭素滴眼液及其制备方法
US12527688B2 (en) Dissolvable medical device for drugs delivery
US20250195416A1 (en) Dissolvable polymeric ocular insert for drugs delivery
RU2802441C1 (ru) Растворимые полимерные офтальмологические вкладки с биоразлагаемым полимером
WO2024180453A1 (en) Dissolvable polymeric eye inserts with a non-ionic cellulose derivative
KR20220010506A (ko) 젤란검 및 페닐레프린 기반 조성물, 생산 방법 및 안과용 제품으로서의 용도
WO2024180472A1 (en) Ocular inserts
WO2024134361A1 (en) Salt activatable dissolvable polymeric eye inserts and kit of the same
Mundada Update on Polymers for Ocular Drug Delivery

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20211202

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251016

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260127

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260128